Physicians join John Theurer Cancer Center medical staff

January 18, 2020
John Theurer Cancer Center at Hacksensack University Cancer Center announced the appointment of five physicians to its medical staff.
Trend Watch

Cytovia partners with UCSF, New York Stem Cell Foundation to develop novel CAR-NK cell therapies

January 17, 2020
Cytovia Therapeutics announced research partnerships with both The New York Stem Cell Foundation Research Institute and University of California, San…
In the Journals

High BMI linked to longer survival with immunotherapy for non-small cell lung cancer

January 16, 2020
High baseline BMI appeared to be independently associated with improved survival among patients with non-small cell lung cancer who received…
FDA News

FDA grants priority review to Opdivo-Yervoy combination for first-line non-small cell lung cancer

January 15, 2020
The FDA granted priority review to the combination of nivolumab plus ipilimumab for the first-line treatment of patients with metastatic or recurrent…

Addition of pembrolizumab to chemotherapy fails to extend OS in small cell lung cancer

January 14, 2020
The addition of pembrolizumab to first-line chemotherapy extended PFS but failed to significantly extend OS among patients with extensive-stage small…

‘Immunotransplant’ shows potential for non-Hodgkin lymphoma

January 13, 2020
A combination of immunotherapy and stem cell transplantation could benefit patients with treatment-resistant non-Hodgkin lymphoma, according to…

Avelumab maintenance extends OS in advanced urothelial carcinoma

January 12, 2020
The addition of maintenance avelumab to best supportive care extended OS for patients with previously untreated locally advanced or metastatic…

Loncastuximab tesirine appears effective for relapsed or refractory DLBCL

January 11, 2020
Loncastuximab tesirine appeared effective and safe for patients with relapsed or refractory diffuse large B-cell lymphoma, according to topline data…
FDA News

FDA grants rare pediatric disease designation to gene therapy for sickle cell disease

January 10, 2020
The FDA granted rare pediatric disease designation to ARU-1801, an investigational autologous gene therapy, for the treatment of sickle cell disease…
FDA News

FDA approves Keytruda for bladder cancer subset

January 8, 2020
The FDA approved pembrolizumab for treatment of certain patients with bacillus Calmette-Guérin-unresponsive, high-risk nonmuscle-invasive bladder…